Form D · Biotechnology
Indi Molecular, Inc.
Culver City, CA · CIK 0001709279
Offering snapshot reported Jun 20, 2017 · SEC filing
- Reported sold
- $4.48M Indefinite offering
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 6, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 20, 2017 | Initial | $4,475,996 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-289067
Source: Form D, filed Jun 20, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Heather Agnew | Executive |
| Darren Cai | Director |
| Douglas Fisher | Director |
| James Heath | Director |
| Leroy Hood | Director |
| Andreas Jurgeit | Director |
| Albert Luderer | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6162 Bristol Parkway
Culver City, CA, 90230
Culver City, CA, 90230